Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

Obesity alters how medications work, increasing the risk of underdosing, overdosing, and unknown interactions. Are package ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

There may soon be a new medication option for losing weight. Eli Lilly's experimental pill appears to work as well as the ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

GLP-1s like Ozempic, as well as weight-loss surgery, are among the recommendations to treat childhood obesity in the first ...

A new guideline for treating obesity in children and adolescents says medication can be helpful, but that health providers ...